Evaluation of early second trimester maternal serum creatine kinase isoenzyme bb as a marker of poor pregnancy outcome

Chuka B. Jenkins, Alessandro Ghidini, Catherine Y. Spong, Gary S. Eglinton, John C. Pezzullo, Maria Michejda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We hypothesized that maternal serum levels of the isoenzyme creatine kinase (CK)-BB which is highly expressed in the placenta, may be elevated during the early second trimester in gestations destined to deliver prematurely or of a small-for-gestational-age infant (birthweight below 10th percentile). To test this hypothesis, we compared maternal serum CK-BB levels and percentage of CK-BB over total CK, in 69 normal pregnancies (delivering at term of appropriate-for-gestational-age infants) with those of 25 cases complicated by preterm delivery at < 34 weeks (n=14), of a small-for-gestational-age infant (n=8), or both (n=3). No differences were present in maternal serum CK BB levels between normal and complicated pregnancies. Moreover, no correlation was found between gestational age at delivery and CK BB levels (r=0.03; p=0.7).

Original languageEnglish (US)
Pages (from-to)356-359
Number of pages4
JournalFetal Diagnosis and Therapy
Volume12
Issue number6
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

BB Form Creatine Kinase
Second Pregnancy Trimester
Pregnancy Outcome
Creatine Kinase
Isoenzymes
Mothers
Small for Gestational Age Infant
Serum
Pregnancy
Gestational Age
Placenta

Keywords

  • Creatine kinase
  • Pregnancy complications
  • Tissue ischemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynecology

Cite this

Evaluation of early second trimester maternal serum creatine kinase isoenzyme bb as a marker of poor pregnancy outcome. / Jenkins, Chuka B.; Ghidini, Alessandro; Spong, Catherine Y.; Eglinton, Gary S.; Pezzullo, John C.; Michejda, Maria.

In: Fetal Diagnosis and Therapy, Vol. 12, No. 6, 01.01.1997, p. 356-359.

Research output: Contribution to journalArticle

Jenkins, Chuka B. ; Ghidini, Alessandro ; Spong, Catherine Y. ; Eglinton, Gary S. ; Pezzullo, John C. ; Michejda, Maria. / Evaluation of early second trimester maternal serum creatine kinase isoenzyme bb as a marker of poor pregnancy outcome. In: Fetal Diagnosis and Therapy. 1997 ; Vol. 12, No. 6. pp. 356-359.
@article{abcd38c180984382b745465ccfc3c78e,
title = "Evaluation of early second trimester maternal serum creatine kinase isoenzyme bb as a marker of poor pregnancy outcome",
abstract = "We hypothesized that maternal serum levels of the isoenzyme creatine kinase (CK)-BB which is highly expressed in the placenta, may be elevated during the early second trimester in gestations destined to deliver prematurely or of a small-for-gestational-age infant (birthweight below 10th percentile). To test this hypothesis, we compared maternal serum CK-BB levels and percentage of CK-BB over total CK, in 69 normal pregnancies (delivering at term of appropriate-for-gestational-age infants) with those of 25 cases complicated by preterm delivery at < 34 weeks (n=14), of a small-for-gestational-age infant (n=8), or both (n=3). No differences were present in maternal serum CK BB levels between normal and complicated pregnancies. Moreover, no correlation was found between gestational age at delivery and CK BB levels (r=0.03; p=0.7).",
keywords = "Creatine kinase, Pregnancy complications, Tissue ischemia",
author = "Jenkins, {Chuka B.} and Alessandro Ghidini and Spong, {Catherine Y.} and Eglinton, {Gary S.} and Pezzullo, {John C.} and Maria Michejda",
year = "1997",
month = "1",
day = "1",
doi = "10.1159/000264505",
language = "English (US)",
volume = "12",
pages = "356--359",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Evaluation of early second trimester maternal serum creatine kinase isoenzyme bb as a marker of poor pregnancy outcome

AU - Jenkins, Chuka B.

AU - Ghidini, Alessandro

AU - Spong, Catherine Y.

AU - Eglinton, Gary S.

AU - Pezzullo, John C.

AU - Michejda, Maria

PY - 1997/1/1

Y1 - 1997/1/1

N2 - We hypothesized that maternal serum levels of the isoenzyme creatine kinase (CK)-BB which is highly expressed in the placenta, may be elevated during the early second trimester in gestations destined to deliver prematurely or of a small-for-gestational-age infant (birthweight below 10th percentile). To test this hypothesis, we compared maternal serum CK-BB levels and percentage of CK-BB over total CK, in 69 normal pregnancies (delivering at term of appropriate-for-gestational-age infants) with those of 25 cases complicated by preterm delivery at < 34 weeks (n=14), of a small-for-gestational-age infant (n=8), or both (n=3). No differences were present in maternal serum CK BB levels between normal and complicated pregnancies. Moreover, no correlation was found between gestational age at delivery and CK BB levels (r=0.03; p=0.7).

AB - We hypothesized that maternal serum levels of the isoenzyme creatine kinase (CK)-BB which is highly expressed in the placenta, may be elevated during the early second trimester in gestations destined to deliver prematurely or of a small-for-gestational-age infant (birthweight below 10th percentile). To test this hypothesis, we compared maternal serum CK-BB levels and percentage of CK-BB over total CK, in 69 normal pregnancies (delivering at term of appropriate-for-gestational-age infants) with those of 25 cases complicated by preterm delivery at < 34 weeks (n=14), of a small-for-gestational-age infant (n=8), or both (n=3). No differences were present in maternal serum CK BB levels between normal and complicated pregnancies. Moreover, no correlation was found between gestational age at delivery and CK BB levels (r=0.03; p=0.7).

KW - Creatine kinase

KW - Pregnancy complications

KW - Tissue ischemia

UR - http://www.scopus.com/inward/record.url?scp=0031444411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031444411&partnerID=8YFLogxK

U2 - 10.1159/000264505

DO - 10.1159/000264505

M3 - Article

C2 - 9475367

AN - SCOPUS:0031444411

VL - 12

SP - 356

EP - 359

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 6

ER -